Agile Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Agile Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 80% to $19,593,000. The net income raised on -$14,465,000 and profit margin reached -74%. Total operating expenses were $30,499,000.
Profit Margin
| 2014 | 0 | -16.07M | |
|---|---|---|---|
| 2015 | 0 | -30.33M | |
| 2016 | 0 | -28.74M | |
| 2017 | 0 | -28.30M | |
| 2018 | 0 | -19.77M | |
| 2019 | 0 | -18.44M | |
| 2020 | 749K | -54.68M | -7301.2% |
| 2021 | 4.10M | -76.58M | -1867.47% |
| 2022 | 10.88M | -25.41M | -233.48% |
| 2023 | 19.59M | -14.46M | -73.83% |
AGRX Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 19.59M | 10.88M | 4.10M | 749K | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 8.97M | 6.83M | 10.71M | 282K | 163K | 0 | 23K | 0 | 18K | 0 |
Gross profit | 10.61M | 4.04M | -6.61M | 467K | -163K | 0 | -23K | 0 | -18K | 0 |
Operating exp. | ||||||||||
Research and development | 2.22M | 3.25M | 6.24M | 13.5M | 9.85M | 9.77M | 14.42M | 20.92M | 25.62M | 13.36M |
Selling and marketing | 17.76M | 30.36M | 43.44M | 23.28M | 1.08M | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 30.49M | 45.48M | 64.38M | 49.52M | 18.85M | 18.51M | 26.81M | 29.72M | 33.08M | 18.51M |
Operating income | -19.88M | -41.43M | -71.00M | -49.05M | -18.85M | -19.53M | -26.81M | -29.72M | -33.08M | -18.51M |
Other income (expenses), net | 5.41M | 11.34M | -3.88M | -2.8M | 252K | -990K | -1.49M | 234K | -3.21M | -1.21M |
Income before tax | -14.46M | -30.08M | -74.89M | -51.85M | -18.60M | -20.25M | -28.30M | -31.81M | -36.30M | -19.73M |
Income tax expense | 1.41M | -4.67M | 1.69M | 2.83M | -163K | -477K | 1.91M | -3.07M | -5.97M | -3.65M |
Net income | -14.46M | -25.41M | -76.58M | -54.68M | -18.44M | -19.77M | -28.30M | -28.74M | -30.33M | -16.07M |
Earnings per share | ||||||||||
Basic EPS | -6.71 | -58.79 | -63.11K | -1.29K | -746.2 | -1.15K | -1.82K | -2.03K | -2.75K | -2.82K |
Diluted EPS | -6.71 | -58.79 | -63.11K | -1.29K | -746.2 | -1.15K | -1.82K | -2.03K | -2.75K | -2.82K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |